Concealed Drug Trial Results Mislead Doctors & Put Children’s Lives at Risk – NYT Thu, 22 Jul 2004 The inordinate influence that drug companies wield on government healthcare regulatory policies–through campaign contributions to elected officials and lucrative job offers to public officials–has seriously compromised children’s safety in numerous ways. An…
Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT Mon, 26 Jul 2004 The New York Times reports that the Bush administration is actively blocking individual citizens who have been seriously harmed from drug-related hazards from suing drug manufacturers. The administration argues that “if a local judge…
Cong Hinchey PRESS CONFERENCE Re: Drug Co. Influence on FDA Sat, 10 Jul 2004 New York Congressman Maurice Hinchey (House Appropriations Committee) is holding a press conference on Tuesday, July 13, 2004, at 10:30 AM to address issues of concern about undue influence by drug manufacturers on FDA policy and…
http://www.illinoisleader.com/opinion/opinionview.asp?c=17908 GUEST OPINION: Maybe legislators should be mentally evaluated, too Friday, July 23, 2004 – by Karen Hayes, associate director of Concerned Women for America-Illinois If Illinois’ Children’s Mental Health Partnership Preliminary Plan goes into effect as planned next year, standardized academic tests will include mental health evaluation. [On Friday,…
Bill Moyers: the Real Show…Congressional hearing was abruptly cancelled Tue, 27 Jul 2004 Congressman Greenwoods’ retirement statement indicates that he had negotiated his contract with Biotechnology Industry Org–a company that represents the very industry he was in the middle of investigating–on Tuesday. http://www.house.gov/greenwood/press_releases/2004/pr040722.html Tuesday was the precise day that Greenwood…
Paxil for Children: Safety, Efficacy Aren’t Established – Letter WSJ Fri, 9 Jul 2004 Dr. Arnold Relman, Professor Emeritus, Medicine and Social Medicine, Harvard Medical School, and former editor of The New England Journal of Medicine, responds to a June 21 editorial in The Wall Street Journal. The editorial attacked…
Corruption of Cong by Pharma: Greenwood offered job / drops Pharma hearing Tue, 20 Jul 2004 Related link: Cong Greenwood’s version Big Pharma buys a congressman and derails a public hearing focusing on pharmaceutical company concealment of evidence showing antidepressants increase risks of harm and show no benefit for children…
Cong Greenwood’s version Wed, 21 Jul 2004 Congressman James Greenwood called at 4:05 to inform AHRP of the following: He has resigned from the chairmanship of the House subcommittee on oversight and investigations today. He was offered the job with Biotechnology Industry Organization on Friday. He objected to being accused…
Cong hearing on July 20 is postponed Sun, 18 Jul 2004 We have just received word from the attorney in charge of the hearing that had been scheduled for Tuesday, July 20th that it will not take place on July 20th: “due to a personal matter that Mr. Greenwood was…
Janssen Pharma Admits Hiding Risperdal Drug Risks / TMAP & Illinois Mental Health Screening Plan Sat, 24 Jul 2004 The Miami Herald reports (below) that in a letter to doctors, Janssen Pharmacia, manufacturer of the highly promoted drug, Risperdal (risperidone), admitted “misleading doctors and other healthcare providers about the safety…
Fast growing business: Unethical clinical trials in India – Asia Times Tue, 27 Jul 2004 Asia Times reports: “India increasingly emerges as a preferred destination for outsourcing clinical trials – testing of new drugs on humans – the country may also be heading toward providing the greatest source of human…
Statin-Cholesterol Guidelines–Industry influenced? Wed, 14 Jul 2004 Scientific journal editors are scrambling about how to react to bad publicity emanating from public disclosure that the scientific reports they have published are likely to be biased because the authors’ had financial ties to the companies whose drugs / devices they report…
